Browse by author
Lookup NU author(s): Muntaser Omari, Dr Mohammad Alkhalil
This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
© 2026 The Author(s). Published by IMR Press.Background: Transcatheter aortic valve implantation (TAVI) is an established treatment for severe aortic stenosis. The two most widely used platforms are either balloon-expandable intra-annular valve (BEV, Edwards) or self-expanding supra-annular valve (SEV) from Medtronic. Comparative data related to clinical and sub-clinical valve thrombosis are limited. The aim of this study-level meta-analysis is to evaluate its incidence and whether this translates into any difference in clinical outcomes. Methods: Electronic databases were searched from inception through to October 2025 to identify randomised clinical trials of patients receiving either platform. Rates of clinical and subclinical valve thrombosis were identified and compared between the two groups. Results: In five randomized controlled trials including 1877 patients, the risk of clinical and sub-clinical valve thrombosis was relatively low in both groups. There was a significant 81% reduction in clinical valve thrombosis in patients undergoing SEV compared to BEV [0.4% vs. 2.1%; rate ratio (RR) 0.19, 95% confidence interval (CI) (0.04 to 0.86), p = 0.03]. Similarly, the risk of sub-clinical valve thrombosis was significantly lower in the SEV group [0.6% vs. 3.6%; RR 0.22, 95% CI (0.07 to 0.65), p = 0.006]. This difference was not translated into increased risk of stroke, valve re-intervention, or death. Conclusion: Patients undergoing TAVI using SEV compared to BEV have a lower risk of clinical and sub-clinical valve thrombosis in randomized trials, which is largely influenced by small annulus anatomy. Larger studies with longer term follow-up or using a dedicated imaging protocol may provide better insights into the clinical sequelae of this phenomenon.
Author(s): Ali M, Paraskevi T, Omari M, Farag M, Kuzemczak M, Alkhalil M
Publication type: Review
Publication status: Published
Journal: Reviews in Cardiovascular Medicine
Year: 2026
Volume: 27
Issue: 4
Print publication date: 01/04/2026
Online publication date: 21/04/2026
Acceptance date: 09/01/2026
ISSN (print): 1530-6550
ISSN (electronic): 2153-8174
Publisher: IMR Press Limited
URL: https://doi.org/10.31083/RCM48459
DOI: 10.31083/RCM48459
Data Access Statement: Data are available from the corresponding author on a reasonable request.
